First Mercantile Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

First Mercantile Trust’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$252K	Buy	338 +243	+256%	+$182K	0.03%	326
2021 Q2	$61K	Sell	95 -5	-5%	-$3.04K	0.01%	777
2021 Q1	$57K	Buy	+100	New	+$59.2K	0.01%	767
2014 Q2	–	Sell	-8,900	Closed	-$1.14M	–	1200
2014 Q1	$1.14M	Buy	+8,900	New	+$1.14M	0.08%	321

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

First Mercantile Trust's BIO Position: Q3 2021 in Review

First Mercantile Trust increased its Bio-Rad Laboratories Class A (BIO) stake by 256% in Q3 2021, buying an estimated $182K and bringing the position to 338 shares worth $252K. The position accounts for 0.03% of the portfolio, ranked #326.

First Mercantile Trust first reported a position in BIO in Q1 2014 and has held it in 4 quarters since. The position peaked at $1.14M in Q1 2014. 508 funds tracked by Wall St. Rank hold BIO as of Q3 2021.

First Mercantile Trust held 338 shares of Bio-Rad Laboratories Class A worth $252K as of Q3 2021.
First Mercantile Trust bought 243 Bio-Rad Laboratories Class A shares in Q3 2021, an estimated $182K.
Bio-Rad Laboratories Class A made up 0.03% of First Mercantile Trust's portfolio in Q3 2021, its #326 holding.
First Mercantile Trust first reported a position in Bio-Rad Laboratories Class A in Q1 2014 and has held it in 4 quarters since.
First Mercantile Trust's Bio-Rad Laboratories Class A position peaked at $1.14M in Q1 2014.
508 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.